TARS files Form 144 reporting insider share transactions

TARS disclosed notices under Rule 144 for transactions in its common stock.

Accepted by SEC EDGAR 03/18/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TARS disclosed notices under Rule 144 for transactions in its common stock. The filing lists a Restricted Stock Vesting entry of 3,610 shares dated 03/17/2026 attributed to Fidelity Brokerage Services LLC as compensation. The filing also records sales by Seshadri Neervannan of 8,366 shares on 03/04/2026 and 3,125 shares on 03/17/2026, with proceeds shown alongside each sale.

Insights

Securities Compliance Attorney

Rule 144 notices list recent dispositions and a compensation vesting event.

The filing records a Restricted Stock Vesting of 3,610 shares on 03/17/2026 and two reported dispositions by Seshadri Neervannan of 8,366 and 3,125 shares on 03/04/2026 and 03/17/2026, respectively. Each transaction line includes a dollar amount labeled as proceeds.

These entries are procedural notices under Rule 144. Timing, transfer mechanics, and whether sales were open-market or via broker are not detailed here; subsequent confirmations or broker statements would clarify execution method and actual settlement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TARS Form 144 disclose about recent insider sales?

The filing shows sales by Seshadri Neervannan of 8,366 shares on 03/04/2026 and 3,125 shares on 03/17/2026. Each sale entry lists the proceeds in dollars adjacent to the share count.

Did TARS record any compensation-related share events in the filing?

Yes. The notice lists a Restricted Stock Vesting of 3,610 shares dated 03/17/2026 attributed to Fidelity Brokerage Services LLC and labeled as Compensation in the filing.

Who is named as the broker or custodian on the TARS filing?

The filing lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI associated with the listed common shares and the 3,610-share vesting entry on 03/17/2026.

Do these Form 144 entries confirm how the shares were sold?

The notice records share counts, dates, and dollar amounts but does not specify execution method. The filing does not detail whether sales were open-market, block trades, or transfers; execution mechanics are not provided here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001827584
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tarsus Pharmaceuticals, Inc.
SEC File Number	001-39614
Address of Issuer	15440 LAGUNA CANYON ROAD IRVINE CALIFORNIA 92618
Phone	(949) 409-9820
Name of Person for Whose Account the Securities are To Be Sold	Neervannan Seshadri
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3610	248042.38	42557492	03/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/17/2026	Restricted Stock Vesting	Issuer			3610	03/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Seshadri Neervannan 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/04/2026	8366	641421.22
Seshadri Neervannan 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/17/2026	3125	216920.94

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Seshadri Neervannan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)